Eligibility criteria
Condition
Ulcerative Colitis
Sex
Females and Males
Age
18-75 years
Inclusion criteria
Show details
- Diagnosis of ulcerative colitis for greater than/equal to 4 months.
- Moderate to severe active ulcerative colitis
- Inadequate response to, loss of response to, or intolerance to at least one
conventional therapy for UC.
Exclusion criteria
Show details
- Pregnant or breastfeeding
- Clinical findings suggestive of Crohn's Disease
- History of bowel surgery within 6 months
Trial Details
Administration
Tablets
Placebo
Yes only
Duration
Follow up: 4 weeks
Screening: Up to 6 weeks
Treatment: 32 weeks
Site Visits
Follow up: 1 visits
Screening: Up to 2 visits
Treatment: 9 visits
Prior Approval
The study drug has not been approved yet.
Post-Trial Access to Study Drug
Not planned